After partnership with RWJ, Rutgers Cancer Institute offering new treatment, payment options for breast cancer

October 11, 2017

Following in the footsteps of Hackensack Meridian Health‘s recent announcement that it would offer an upfront payment structure to breast cancer patients, said Dr. Bruce Haffty, a Rutgers Medical School and chair of the radiation oncology unit at the Cancer Institute said Rutgers/RWJ, is considering the same thing. Earlier this month, Dr. Andrew Pecora, chief innovation officer and president of Physician Enterprise at Hackensack Meridian Health, announced that the system’s breast cancer treatment center would take upfront payments from breast cancer patients that would cover up to a year’s worth of treatment as part of its move toward value-based care. Dr. Pecora, speaking at New Jersey Business and Industry Association’s Innovation Summit earlier this month, argued that the new billing system would make treatment more affordable and simpler for patients, and that doctors could focus more on patients, rather than delivering bulk medicine.

Read full article on